ArticleAmerican journal of cancer research2020

Preventive effect of celecoxib in sorafenib-related hand-foot syndrome in hepatocellular carcinoma patients, a single-center, open-label, randomized, controlled clinical phase III trial.

Jian-Cong Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.